Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019

Details for Mechanism ID: 17832
Country/Region: South Sudan
Year: 2016
Main Partner: Catholic Medical Mission Board
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $1,610,620 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $65,722
Health Systems Strengthening (OHSS) $31,899
Testing: HIV Testing and Counseling (HVCT) $705,581
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $74,896
Treatment: Adult Treatment (HTXS) $703,881
Treatment: Pediatric Treatment (PDTX) $28,641
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,217
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 936
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 20,014
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 12,246
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 34,413
HTS_TST Service Delivery Point (Facility): Other PITC 2017 4,345
HTS_TST Service Delivery Point (Facility): PMTCT 2017 5,537
HTS_TST Service Delivery Point (Facility): VCT 2017 24,531
HTS_TST Sum of Aggregated Age/Sex <15 2017 2,153
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 32,260
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 34,413
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 227
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 211
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,002
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 834
PMTCT_ART Already on ART at beginning of current pregnancy 2017 234
PMTCT_ART New on ART 2017 201
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 4,025
PMTCT_STAT By: Known positives at entry 2017 1,550
PMTCT_STAT By: Number of new positives identified 2017 2,475
PMTCT_STAT Number of new ANC and L&D clients 2017 4,025
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 4,025
PMTCT_STAT Sum of Positives Status disaggregates 2017 4,025
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 7
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 7
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 2,193
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 1,343
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 133
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 102
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 3,771
TX_CURR Aggregated Age/Sex: <15 Female 2017 206
TX_CURR Aggregated Age/Sex: <15 Male 2017 159
TX_CURR Aggregated Age/Sex: 15+ Female 2017 3,551
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,207
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 6,123
TX_CURR Sum of Aggregated Age/Sex <15 2017 365
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 5,758
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 6,123
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 72
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 56
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,365
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 845
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,338
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,338